EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wharton’s jelly insufficiency and its implications for perinatal outcomes and regenerative medicine: A review

Umm E. Habiba, Sabiha Shamim, Iqra Sarwar, David Lawrence Greene

Biomolecules and Biomedicine · 19.11.2026

DOI: 10.17305/bb.2026.15130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 19.11.2026. Verfasst von Umm E. Habiba und 3 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wharton’s jelly (WJ) is the hydrated extracellular matrix (ECM) of the umbilical cord, providing mechanical protection for the umbilical vessels and a niche for WJ-derived mesenchymal stromal cells (WJ-MSCs). This narrative review examines WJ insufficiency in relation to perinatal vascular risk and the functional quality of cells harvested for regenerative medicine. PubMed and Google Scholar were searched through October 2026 for studies of WJ structure, cord pathology, prenatal assessment, and WJ-MSC function. A lean cord, defined by a cross-sectional area below the 10th percentile for gestational age, was reported in 73.8% of fetuses with fetal growth restriction (FGR) in one cited cohort. The reported clinical spectrum includes reduced umbilical vein blood flow, thrombosis, and intrauterine fetal death (IUFD). Nine case reports and case series published between 1978 and 2021 describe structural cord abnormalities associated with WJ deficiency. Broader clinical findings are organized into a proposed five-tier severity continuum that has not been prospectively validated. WJ-MSCs from pregnancies complicated by gestational diabetes mellitus (GDM) or maternal obesity show functional alterations that are not captured by cell yield alone. Whether reduced WJ content or a lean cord independently lowers MSC potency remains untested. For preeclampsia and intrauterine infection, the proposed effects on WJ-MSC quality are inferred from adjacent evidence rather than demonstrated directly. Sonographic WJ-area assessment, Doppler monitoring, molecular biomarkers, and potency-based donor stratification are proposed research approaches. Prospective studies linking antenatal WJ measurements to perinatal outcomes and post-isolation MSC function are needed before the severity framework or proposed surveillance and cord-banking strategies can be adopted clinically.

Zitieren

APA

Habiba, U. E., Shamim, S., Sarwar, I., & Greene, D. L. (2026). Wharton’s jelly insufficiency and its implications for perinatal outcomes and regenerative medicine: A review. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.15130

Vancouver

Habiba UE, Shamim S, Sarwar I, Greene DL. Wharton’s jelly insufficiency and its implications for perinatal outcomes and regenerative medicine: A review. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.15130

BibTeX
@article{Habiba2026,
  author = {Habiba, Umm E. and Shamim, Sabiha and Sarwar, Iqra and Greene, David Lawrence},
  title = {Wharton’s jelly insufficiency and its implications for perinatal outcomes and regenerative medicine: A review},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.15130}
}
Kostenlos starten →